293 (HEK-293) |
Human kidney embryo cell line; normal |
CRL-1537 |
769-P |
Human kidney clear cell adenocarcinoma cell line; mutated VHL (codes 2, 180, point mutations, Pro2Ser, Ile180Asn) and VHL promoter hypermethylation-no VHL mRNA, no HIF-1α |
CRL-1933 |
786-O |
Human kidney clear cell carcinoma cell line, renal cell adenocarcinoma; non-functional VHL(code104,1 base deletion), no HIF-1α , high HIF-2α |
CRL-1932 |
A-498 |
Human male kidney clear cell carcinoma cell line; mutated VHL (code142-3, 4 bases deletion), no HIF-1α( with mRNA), high HIF-2α, SETD2 mutation, |
HTB-44 |
| SW-156 |
Hypernephroma |
CRL-2175 |
| SW-839 |
Human Kidney clear cell carcinoma cell line; mutated VHL (code142-3, 4 bases deletion) |
HTB-49, NA on ATCC anymore |
A-704 |
Human male kidney adenocarcinoma cell line; mutated VHL, homo-mutated PBRM1 |
HTB-45 |
ACHN |
Human kidney adenocarcinoma cell line; no VHL mutation, NF2 mutation, hetero-mutated PBRM1 |
CRL-1611 |
CaKi-1 |
Human kidney clear cell carcinoma(skin-metastatic) cell line; no VHL mutation |
HTB-46 |
CaKi-2 |
Human kidney paipllary carcinoma cell line; no VHL mutation |
HTB-47; ref |
| SN12C |
Human male mixed clear cell/granular cell RCC (invasive, metastatic) cell line; no VHL mutation, NF2 mutation |
from NCI, ref |
| SKRC39 |
Human kidney papillary carcinoma cell line; BHD missense mutation (Ala238Val) |
From NCI, ref |
| UOK257 |
Human clear cell RCC from a male BHD patient's kidney tissue; BHD mutation |
From NCI, ref1-ref2 |
| TK-10 |
Human male RCC (papillary, spindle cell pattern); no VHL mutation |
From NCI, ref |
| RXF-393 |
Human kidney clear cell carcinoma cell line(recurrent) |
From NCI |
RC-124 |
Human kidney cell line |
From CLS |
RCC-AB |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-ER |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-ER |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-EW |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-FG1 |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-FG2 |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-GH |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-GS |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-GW |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-HB |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-HS |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-JF |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-JW |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-KL |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-KP |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-LR |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-MF |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-MH |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-OF1 |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-PR |
Human kidney clear cell carcinoma cell line |
From CLS |
RCC-WK |
Human kidney clear cell carcinoma cell line |
From CLS |
SK-NEP-1 |
Human kidney (Wilm's Tumor) cell line |
From CLS |
WT-CLS1 |
Human kidney (Wilm's Tumor) cell line |
From CLS |
| OS-RC-2 |
Human renal cell carcinoma (clear cell); homo-mutated PBRM1 |
Japan, ref |
| BFTC-909 |
Kidney urothelial carcinoma (TCC sarcomatoid); hetero-mutated PBRM1 |
Taiwan |
